Inspire Medical Systems, Inc. APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
Inspire Medical Systems, Inc. (INSP) reported APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition of $31.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition · last filed 2026-08-03
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-06-30 was $31.23M, a 25.16% decline year-over-year.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2026-03-31 was $30.69M, a 1.18% decline year-over-year.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-09-30 was $29.47M, a 4.41% increase year-over-year.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for the quarter ending 2025-06-30 was $41.72M, a 29.09% increase year-over-year.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2025 was $130.26M, a 12.29% increase from fiscal 2024.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2024 was $116.01M, a 40.67% increase from fiscal 2023.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2023 was $82.47M, a 58.69% increase from fiscal 2022.
- Inspire Medical Systems, Inc. apic, share-based payment arrangement, option, increase for cost recognition for fiscal 2022 was $51.97M, a 98.53% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.23M 10-Q · filed 2026-08-03 | $61.91M derived: sum of 2 quarters · filed 2026-08-03 | ||
| 2026-03-31 | $30.69M 10-Q · filed 2026-08-03 | |||
| 2025-12-31 | $130.26M 10-K · filed 2026-02-13 | |||
| 2025-09-30 | $29.47M 10-Q · filed 2025-11-03 | $71.19M derived: sum of 2 quarters · filed 2026-08-03 | $102.25M derived: sum of 3 quarters · filed 2026-08-03 | |
| 2025-06-30 | $41.72M 10-Q · filed 2026-08-03 | $72.78M derived: sum of 2 quarters · filed 2026-08-03 | ||
| 2025-03-31 | $31.06M 10-Q · filed 2026-08-03 | |||
| 2024-12-31 | $116.01M 10-K · filed 2026-02-13 | |||
| 2024-09-30 | $28.22M 10-Q · filed 2025-11-03 | $60.55M derived: sum of 2 quarters · filed 2025-11-03 | $86.87M derived: sum of 3 quarters · filed 2025-11-03 | |
| 2024-06-30 | $32.32M 10-Q · filed 2025-11-03 | $58.64M derived: sum of 2 quarters · filed 2025-11-03 | ||
| 2024-03-31 | $26.32M 10-Q · filed 2025-11-03 | |||
| 2023-12-31 | $82.47M 10-K · filed 2026-02-13 | |||
| 2023-09-30 | $19.83M 10-Q · filed 2024-11-04 | $41.40M derived: sum of 2 quarters · filed 2024-11-04 | $59.62M derived: sum of 3 quarters · filed 2024-11-04 | |
| 2023-06-30 | $21.57M 10-Q · filed 2024-11-04 | $39.79M derived: sum of 2 quarters · filed 2024-11-04 | ||
| 2023-03-31 | $18.23M 10-Q · filed 2024-11-04 | |||
| 2022-12-31 | $51.97M 10-K · filed 2025-02-10 | |||
| 2022-09-30 | $14.59M 10-Q · filed 2023-11-07 | $27.25M derived: sum of 2 quarters · filed 2023-11-07 | $36.97M derived: sum of 3 quarters · filed 2023-11-07 | |
| 2022-06-30 | $12.66M 10-Q · filed 2023-11-07 | $22.38M derived: sum of 2 quarters · filed 2023-11-07 | ||
| 2022-03-31 | $9.72M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $26.18M 10-K · filed 2024-02-09 | |||
| 2021-09-30 | $6.81M 10-Q · filed 2022-11-01 | $13.15M derived: sum of 2 quarters · filed 2022-11-01 | $19.15M derived: sum of 3 quarters · filed 2022-11-01 | |
| 2021-06-30 | $6.34M 10-Q · filed 2022-11-01 | $12.34M derived: sum of 2 quarters · filed 2022-11-01 | ||
| 2021-03-31 | $6.00M 10-Q · filed 2022-11-01 | |||
| 2020-12-31 | $12.82M 10-K · filed 2023-02-10 | |||
| 2020-09-30 | $3.31M 10-Q · filed 2021-11-02 | $6.21M derived: sum of 2 quarters · filed 2021-11-02 | $8.96M derived: sum of 3 quarters · filed 2021-11-02 | $10.86M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $2.90M 10-Q · filed 2021-11-02 | $5.65M derived: sum of 2 quarters · filed 2021-11-02 | $7.54M derived: sum of 3 quarters · filed 2022-02-15 | $9.07M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $2.75M 10-Q · filed 2021-11-02 | $4.64M derived: sum of 2 quarters · filed 2022-02-15 | $6.17M derived: sum of 3 quarters · filed 2022-02-15 | $7.55M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $3.42M derived: sum of 2 quarters · filed 2022-02-15 | $4.81M derived: sum of 3 quarters · filed 2022-02-15 | $6.20M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.52M 10-Q · filed 2020-11-02 | $2.91M derived: sum of 2 quarters · filed 2020-11-02 | $4.30M 10-Q · filed 2019-11-05 | $4.83M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.39M 10-Q · filed 2020-11-02 | $2.78M 10-Q · filed 2019-08-06 | $3.30M derived: sum of 3 quarters · filed 2021-02-24 | $3.67M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.39M 10-Q · filed 2020-11-02 | $1.91M derived: sum of 2 quarters · filed 2021-02-24 | $2.29M derived: sum of 3 quarters · filed 2021-02-24 | $2.56M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $523.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $895.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.16M derived: sum of 3 quarters · filed 2021-02-24 | $1.22M 10-K · filed 2021-02-24 |
| 2018-09-30 | $372.00K 10-Q · filed 2019-11-05 | $641.00K derived: sum of 2 quarters · filed 2019-11-05 | $696.00K 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $269.00K 10-Q · filed 2019-08-06 | $324.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $55.00K 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | $243.00K 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $248.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |